Evidence map›Paper›PMID 39016343›Full record

ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2024

Trends and epidemiology in robotic-assisted total knee arthroplasty: Reduced complications and shorter hospital stays.

David Maman, Lior Laver, Roland Becker, Loai Ahmad Takrori, Assil Mahamid, Binyamin Finkel, Hadar Gan-Or, Yaniv Yonai, Yaron Berkovich

Abstract read
In one paragraph

Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Comparable clinical outcomes in functionally aligned computer-assisted and image-based robotic assisted total knee arthroplasty.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026
    Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David MamanDepartment of Orthopedics, Carmel Medical Center, Haifa, Israel.ORCID http://orcid.org/0009-0009-4127-4415
Lior LaverRappaport Faculty of Medicine, Technion University Hospital (Israel Institute of Technology), Haifa, Israel.
Roland BeckerDepartment of Orthopedics and Traumatology, University Hospital Brandenburg, Berlin, Germany.
Loai Ahmad TakroriDepartment of Orthopedics, Hillel Yaffe Medical Center, Hadera, Israel.
Assil MahamidDepartment of Orthopedics, Hillel Yaffe Medical Center, Hadera, Israel.
Binyamin FinkelDepartment of Orthopedics, Hillel Yaffe Medical Center, Hadera, Israel.
Hadar Gan-OrDepartment of Orthopedics, Hillel Yaffe Medical Center, Hadera, Israel.
Yaniv YonaiDepartment of Orthopedics, Carmel Medical Center, Haifa, Israel.
Yaron BerkovichDepartment of Orthopedics, Carmel Medical Center, Haifa, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study provides an in-depth analysis of the immediate postoperative outcomes and implications or robotic-assisted total knee arthroplasty (RA-TKA) compared with conventional TKA (C-TKA), particularly with regard to mortality, complications, hospital stay and costs, drawing from a comprehensive nationwide data set.

methodsThe Nationwide Inpatient Sample (NIS) database, the largest all-payer inpatient healthcare database in the United States, was used to identify all patients who underwent RA-TKA or C-TKA from 2016 to 2019. A total of 527,376 cases, representing 2,638,679 patients who underwent elective TKA were identified, of which 88,415 had RA-TKA. To mitigate potential variations and selection bias in baseline characteristics between the two groups, a propensity score-matched analysis was employed to further balance and refine our data set, resulting in 176,830 patients evenly distributed between the groups. Analysis was performed according to demographics, immediate post-operative complications, and economic data, including payor class, length of stay and total charges.

resultsThere was a marked shift towards RA-TKA, from an initial 0.70% in 2016 to a notable 7.30% by 2019. Patients who underwent RA-TKA were slightly younger (66.2 ± SD years), compared to the C-TKA group (66.7 ± SD years). Hospital stay was 1.89 days and 2.29 days for RA-TKA and C-TKA, respectively. Charges metrics revealed slightly higher charges for RA-TKA. Less postoperative complications were found in the RA-TKA group, such as blood loss, anaemia, acute kidney injury, venous thromboembolism, pulmonary embolism, pneumonia and surgical wound complication. Even following the propensity score matching, these findings remained consistent and statistically significant.

conclusionsRA-TKA use in the United States has grown substantially in the last few years and has been associated with significantly reduced immediate post-operative complications and length of hospital stay compared to C-TKA, offering safer surgical management for TKA patients. Further studies on the short- and long-term outcomes of RA-TKA would improve the understanding of the full potential of this technology. LEVELS OF EVIDENCE: Level III.

Indexed as

Arthroplasty, Replacement, KneeLength of StayPostoperative ComplicationsRobotic Surgical ProceduresAgedDatabases, FactualFemaleHumansMaleMiddle AgedPropensity ScoreUnited Statesnational inpatient samplepost‐operative complicationsrobotic knee surgerytotal knee arthroplasty

Identifiers

PMID39016343
PMCPMC11605021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.